Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
strategic
7h agoEli Lilly and Company to invest US$1.2 billion in Puerto Rico manufacturing hub
Eli Lilly announced it will invest more than US$1.2 billion to expand its manufacturing site in Carolina, Puerto Rico, part of a broader push to bolster U.S. production capacity amid global supply-chain pressures and tariff risks. The upgraded facility will support the company’s upcoming weight-loss pill, Orforglipron, plus heart, diabetic, cancer and immune disorder treatments. Construction starts in 2026 with production by end-2028; the investment is part of Lilly’s previously announced ~US$50 billion U.S. manufacturing expansion plan.
strategic
7h agoEli Lilly and Company to invest US$1.2 billion in Puerto Rico manufacturing hub
Eli Lilly announced it will invest more than US$1.2 billion to expand its manufacturing site in Carolina, Puerto Rico, part of a broader push to bolster U.S. production capacity amid global supply-chain pressures and tariff risks. The upgraded facility will support the company’s upcoming weight-loss pill, Orforglipron, plus heart, diabetic, cancer and immune disorder treatments. Construction starts in 2026 with production by end-2028; the investment is part of Lilly’s previously announced ~US$50 billion U.S. manufacturing expansion plan.
strategic
Eli Lilly and Company to invest US$1.2 billion in Puerto Rico manufacturing hub
about 7 hours ago
1 min read
77 words
Eli Lilly invests US$1.2 billion in Puerto Rico facility to strengthen U.S. drug-manufacturing amid tariff and supply-chain risks.
Eli Lilly announced it will invest more than US$1.2 billion to expand its manufacturing site in Carolina, Puerto Rico, part of a broader push to bolster U.S. production capacity amid global supply-chain pressures and tariff risks. The upgraded facility will support the company’s upcoming weight-loss pill, Orforglipron, plus heart, diabetic, cancer and immune disorder treatments. Construction starts in 2026 with production by end-2028; the investment is part of Lilly’s previously announced ~US$50 billion U.S. manufacturing expansion plan.
Eli Lilly announced it will invest more than US$1.2 billion to expand its manufacturing site in Carolina, Puerto Rico, part of a broader push to bolster U.S. production capacity amid global supply-chain pressures and tariff risks. The upgraded facility will support the company’s upcoming weight-loss pill, Orforglipron, plus heart, diabetic, cancer and immune disorder treatments. Construction starts in 2026 with production by end-2028; the investment is part of Lilly’s previously announced ~US$50 billion U.S. manufacturing expansion plan.
Companies:
Eli Lilly and Company
Tags:
global
manufacturing
global
manufacturing
pharma
investment
US
Oct 29, 2025 • 21:02 IST